Abstract
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have